Gil Labrucherie is a seasoned executive with extensive experience in the biopharmaceutical sector, currently serving as Chief Financial Officer and Chief Business Officer at ACELYRIN, INC. since August 2023. Previously, Gil held various leadership roles, including Chief Financial Officer and Chief Operating Officer at Nektar Therapeutics, where responsibilities encompassed financial planning, strategic development, and investor relations. Gil also serves as Managing Trustee of the Bloom Family Trust and as a board member for Rezolute, Inc. and has participated on the board for Valinor Pharma until its acquisition in July 2024. Educational credentials include a Juris Doctor from the University of California, Berkeley - School of Law and a Bachelor of Arts with Highest Honors from the University of California, Davis.
Sign up to view 0 direct reports
Get started
This person is not in any teams